i-sense researchers from Imperial College London and UCL have recently published landmark research on the development of a paper-based point-of-care test for HIV that surpasses the sensitivity of the current industrial gold standard for detection of p24, an early biomarker for HIV.
New research from i-sense at Imperial College London and UCL provides a promising new approach to detecting immunity to Ebola virus infection.
Postdoctoral Research Associate in the i-sense McKendry group at UCL, Dr Harriet Gliddon, recently travelled to South Africa with the support of a UCL Global Engagement Grant. The visit helped Dr Gliddon plan for a study looking at new sequencing technology to diagnose drug-resistant tuberculosis.
Science Minister, Jo Johnson, has announced £3.8M in funding from Engineering and Physical Sciences Research Council (EPSRC) awarded to i-sense IRC Next Steps for pioneering developments of agile early warning sensing systems for infectious disease and antimicrobial resistance.
i-sense researchers at UCL and Imperial are working on a number of projects in collaboration with Africa Health Research Institute (AHRI) to develop and implement diagnostic tools and technologies for those hardest hit by HIV.
Last week, Professor of Biomedical Nanotechnology at UCL and Director of i-sense, Professor Rachel McKendry, and Research Director for Biomedical Materials at Imperial and i-sense Deputy Director, Professor Molly Stevens, visited our collaborators at the Africa Health Research Institute (AHRI).
i-sense members from the McKendry group at UCL and the Peeling group at LSHTM attended the week-long Advanced Course on Diagnostics (ACDx), which took place at the Fondation Merieux Centre for Global Health in Annecy.
This August, i-sense researchers asked festival goers at Greenman Festival to help us contain a mysterious outbreak that is turning people into Llamas!
